Close

Mast Therapeutics (MSTX) Announces Publication of Positive Interim Data from AIR001 Phase 2 in PH-HFpEF

Go back to Mast Therapeutics (MSTX) Announces Publication of Positive Interim Data from AIR001 Phase 2 in PH-HFpEF